Paola Melotti

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

Eitan Kerem, Michael W. Konstan, K. De Boeck et al. · The Lancet Respiratory Medicine · 2014 · 333 citations · Full text

Allergy, Placebo-controlled Phase 3, Clinical Trials +3

Heparan Sulfate Glycosaminoglycans Are Receptors Sufficient To Mediate the Initial Binding of Adenovirus Types 2 and 5

Maria Cristina Dechecchi, Paola Melotti, A. Bonizzato et al. · Journal of Virology · 2001 · 293 citations · Full text

Virus Structure, Adenovirus Types 2, Molecular Virology +15

Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts

Eleonora Cremonini, Emanuele Zonaro, Marta Donini et al. · Microbial Biotechnology · 2016 · 245 citations · Full text

Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells.

Donatella Venturelli, Robert Martinez, Paola Melotti et al. · Proceedings of the National Academy of Sciences · 1995 · 147 citations · Full text

Apoptosis, Immunology, Cell Death +18

Overexpression of the Zinc Finger Protein MZF1 Inhibits Hematopoietic Development from Embryonic Stem Cells: Correlation with Negative Regulation of <i>CD34</i> and c-<i>myb</i> Promoter Activity

Danilo Perrotti, Paola Melotti, Tomasz Skórski et al. · Molecular and Cellular Biology · 1995 · 118 citations · Full text

Genetics, Zinc Finger Protein, Stem Cell Biology +21